These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10873546)

  • 1. Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line.
    Liu YY; Gordienko I; Mathias A; Ma S; Thompson J; Woo JH; Neville DM
    Protein Expr Purif; 2000 Jul; 19(2):304-11. PubMed ID: 10873546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A C terminus cysteine of diphtheria toxin B chain involved in immunotoxin cell penetration and cytotoxicity.
    Dell'Arciprete L; Colombatti M; Rappuoli R; Tridente G
    J Immunol; 1988 Apr; 140(7):2466-71. PubMed ID: 2965187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
    Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
    Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin.
    Kim GB; Wang Z; Liu YY; Stavrou S; Mathias A; Goodwin KJ; Thomas JM; Neville DM
    Protein Eng Des Sel; 2007 Sep; 20(9):425-32. PubMed ID: 17693455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
    Thompson J; Hu H; Scharff J; Neville DM
    J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
    Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
    Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice.
    Vallera DA; Todhunter D; Kuroki DW; Shu Y; Sicheneder A; Panoskaltsis-Mortari A; Vallera VD; Chen H
    Leuk Res; 2005 Mar; 29(3):331-41. PubMed ID: 15661270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous protein.
    Hexham JM; King V; Dudas D; Graff P; Mahnke M; Wang YK; Goetschy JF; Plattner D; Zurini M; Bitsch F; Lake P; Digan ME
    Biotechnol Appl Biochem; 2001 Dec; 34(3):183-7. PubMed ID: 11730486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.
    Compton SJ; Sandhu S; Wijesuriya SJ; Hollenberg MD
    Biochem J; 2002 Dec; 368(Pt 2):495-505. PubMed ID: 12171601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.
    Woo JH; Liu JS; Kang SH; Singh R; Park SK; Su Y; Ortiz J; Neville DM; Willingham MC; Frankel AE
    Protein Expr Purif; 2008 Mar; 58(1):1-11. PubMed ID: 18160309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture.
    Francisco JA; Gawlak SL; Miller M; Bathe J; Russell D; Chace D; Mixan B; Zhao L; Fell HP; Siegall CB
    Bioconjug Chem; 1997; 8(5):708-13. PubMed ID: 9327135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
    Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
    Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant molecules.
    Onda M; Vincent JJ; Lee B; Pastan I
    Bioconjug Chem; 2003; 14(2):480-7. PubMed ID: 12643760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in diphtheria toxin to improve immunotoxin selectivity and understand toxin entry into cells.
    Youle RJ
    Semin Cell Biol; 1991 Feb; 2(1):39-45. PubMed ID: 1954342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials.
    Woo JH; Lee YJ; Neville DM; Frankel AE
    Methods Mol Biol; 2010; 651():157-75. PubMed ID: 20686966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.
    Wan L; Zeng L; Chen L; Huang Q; Li S; Lu Y; Li Y; Cheng J; Lu X
    Protein Expr Purif; 2006 Aug; 48(2):307-13. PubMed ID: 16584889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody internalization after cell surface antigen binding is critical for immunotoxin development.
    Kuo SR; Alfano RW; Frankel AE; Liu JS
    Bioconjug Chem; 2009 Oct; 20(10):1975-82. PubMed ID: 19785403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
    Salvatore G; Beers R; Margulies I; Kreitman RJ; Pastan I
    Clin Cancer Res; 2002 Apr; 8(4):995-1002. PubMed ID: 11948105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of an anti-CD3 immunotoxin increases expression and secretion of molecular chaperone BiP/Kar2p by Pichia pastoris.
    Liu YY; Woo JH; Neville DM
    Appl Environ Microbiol; 2005 Sep; 71(9):5332-40. PubMed ID: 16151122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.